⌘K

Login Start Free

Home/Filings/4/0001209191-22-026150

4//SEC Filing

Pavliv Leo 4

Accession 0001209191-22-026150

CIK 0001087294other

View on SEC.gov Company Profile

Filed

Apr 28, 8:00 PM ET

Accepted

Apr 29, 1:09 PM ET

Size

5.2 KB

Accession

0001209191-22-026150

Insider Transaction Report

Form 4

Period: 2022-03-16

CUMBERLAND PHARMACEUTICALS INCCPIX

Vice President, Operations

Transactions

Award
Options (right to buy)
2022-03-16+5,000→ 5,000 total
Exercise: $2.59From: 2026-03-16Exp: 2032-03-16→ Common Stock (5,000 underlying)

Footnotes (1)

[F1]100% vesting on March 16, 2026.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1

filerCIK 0001408593

Filing Metadata

Form type: 4
Filed: Apr 28, 8:00 PM ET
Accepted: Apr 29, 1:09 PM ET
Size: 5.2 KB

View on SEC.gov